263 related articles for article (PubMed ID: 23053397)
1. The role of PGE2-associated inflammatory responses in gastric cancer development.
Oshima H; Oshima M
Semin Immunopathol; 2013 Mar; 35(2):139-50. PubMed ID: 23053397
[TBL] [Abstract][Full Text] [Related]
2. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways.
Echizen K; Hirose O; Maeda Y; Oshima M
Cancer Sci; 2016 Apr; 107(4):391-7. PubMed ID: 27079437
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
Maeda Y; Echizen K; Oshima H; Yu L; Sakulsak N; Hirose O; Yamada Y; Taniguchi T; Jenkins BJ; Saya H; Oshima M
Cancer Prev Res (Phila); 2016 Mar; 9(3):253-63. PubMed ID: 26888865
[TBL] [Abstract][Full Text] [Related]
6. Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic mice.
Cao D; Jiang J; Tsukamoto T; Liu R; Ma L; Jia Z; Kong F; Oshima M; Cao X
PLoS One; 2015; 10(3):e0120938. PubMed ID: 25781635
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models.
Oshima H; Oguma K; Du YC; Oshima M
Cancer Sci; 2009 Oct; 100(10):1779-85. PubMed ID: 19622104
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of gastric tumors: Wnt activation and PGE2 induction.
Oshima H; Oshima M
Pathol Int; 2010 Sep; 60(9):599-607. PubMed ID: 20712645
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
11. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer.
Itadani H; Oshima H; Oshima M; Kotani H
BMC Genomics; 2009 Dec; 10():615. PubMed ID: 20015407
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
Kong D; Piao YS; Yamashita S; Oshima H; Oguma K; Fushida S; Fujimura T; Minamoto T; Seno H; Yamada Y; Satou K; Ushijima T; Ishikawa TO; Oshima M
Oncogene; 2012 Aug; 31(35):3949-60. PubMed ID: 22139078
[TBL] [Abstract][Full Text] [Related]
13. Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling.
Oshima H; Itadani H; Kotani H; Taketo MM; Oshima M
Cancer Res; 2009 Apr; 69(7):2729-33. PubMed ID: 19318548
[TBL] [Abstract][Full Text] [Related]
14. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide initiates a positive feedback of epidermal growth factor receptor signaling by prostaglandin E2 in human biliary carcinoma cells.
Finzi L; Shao MX; Paye F; Housset C; Nadel JA
J Immunol; 2009 Feb; 182(4):2269-76. PubMed ID: 19201881
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E(2) produced by the lung augments the effector phase of allergic inflammation.
Church RJ; Jania LA; Koller BH
J Immunol; 2012 Apr; 188(8):4093-102. PubMed ID: 22412193
[TBL] [Abstract][Full Text] [Related]
17. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.
Oshima M; Oshima H; Matsunaga A; Taketo MM
Cancer Res; 2005 Oct; 65(20):9147-51. PubMed ID: 16230370
[TBL] [Abstract][Full Text] [Related]
18. CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis.
Ishimoto T; Oshima H; Oshima M; Kai K; Torii R; Masuko T; Baba H; Saya H; Nagano O
Cancer Sci; 2010 Mar; 101(3):673-8. PubMed ID: 20028388
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo.
Ruan D; So SP
Life Sci; 2014 Oct; 116(1):43-50. PubMed ID: 25139833
[TBL] [Abstract][Full Text] [Related]
20. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
